Pedro Vitor Casado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pedro Vitor Casado has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Luisa de Almeida Soares
Department of Physical Therapy, Universidade Federal de Minas Gerais
3 shared publications - Christina Danielli Coelho de Morais Faria
Universidade Federal de Minas Gerais
3 shared publications - Poliana Do Amaral Yamaguchi Benfica
Department of Physical Therapy, Universidade Federal de Minas Gerais
3 shared publications - Aline Alvim Scianni
Department of Physical Therapy, Universidade Federal de Minas Gerais
2 shared publications - Isabel Lopes Ribeiro
Department of Physical Therapy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
2 shared publications Alessandra Swarowsky
Advent Health University
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e84689
Effects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial
Background: Exercises that involve increasing the speed of movements are beneficial for individuals with Parkinson disease (PD) and have the potential to reduce bradykinesia. High-speed bodyweight resistance training is accessible and versatile and can be performed anytime and anywhere, including at home. Furthermore, it is important to consider home exercises that enable treatment continuity and reduce barriers such as transportation difficulties and participation in physical exercise programs. However, we have not identified any studies that have conducted home-based high-speed bodyweight resistance training in individuals with PD. Objective: This protocol aims to investigate the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. Methods: A randomized controlled trial will be performed with 1:1 allocation, blinded assessments, and an intention-to-treat analysis. Altogether, 46 individuals with PD, aged ≥50 years, who have bradykinesia and a sedentary or insufficiently active lifestyle, will be included. Participants will be randomly assigned to either (1) an experimental group (high-speed bodyweight resistance training) or (2) a control group (bodyweight intervention; usual speed). Both groups will perform a home-based, remotely supervised intervention, consisting of 60-minute individual sessions, 3 times per week over 12 weeks, with a trained physiotherapist. The primary outcome is bradykinesia of the lower limbs. The secondary outcomes are mobility, muscle power, dynamic balance, and quality of life. The effects of the training will be analyzed from the collected data by using the intention-to-treat analysis. Between-group differences will be measured by 2-way repeated measures ANOVA, considering the baseline, posttraining follow-up (primary time point), and 4-week follow-up (secondary time point). Results: Recruitment was conducted from October 2024 to October 2025 (n=46). Data collection is currently in the follow-up phase. The results are expected to be analyzed and submitted for publication by May 2026. Conclusions: The results of this trial will likely provide valuable new information on the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. If confirmed, these findings may support the feasibility and effectiveness of an accessible home-based intervention delivered through telerehabilitation, potentially reducing barriers to rehabilitation. Trial Registration: ClinicalTrials.gov NCT06646523; https://clinicaltrials.gov/study/NCT06646523 International Registered Report Identifier (IRRID): DERR1-10.2196/84689
- 4 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e84689
Open AccessEffects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial
Background: Exercises that involve increasing the speed of movements are beneficial for individuals with Parkinson disease (PD) and have the potential to reduce bradykinesia. High-speed bodyweight resistance training is accessible and versatile and can be performed anytime and anywhere, including at home. Furthermore, it is important to consider home exercises that enable treatment continuity and reduce barriers such as transportation difficulties and participation in physical exercise programs. However, we have not identified any studies that have conducted home-based high-speed bodyweight resistance training in individuals with PD. Objective: This protocol aims to investigate the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. Methods: A randomized controlled trial will be performed with 1:1 allocation, blinded assessments, and an intention-to-treat analysis. Altogether, 46 individuals with PD, aged ≥50 years, who have bradykinesia and a sedentary or insufficiently active lifestyle, will be included. Participants will be randomly assigned to either (1) an experimental group (high-speed bodyweight resistance training) or (2) a control group (bodyweight intervention; usual speed). Both groups will perform a home-based, remotely supervised intervention, consisting of 60-minute individual sessions, 3 times per week over 12 weeks, with a trained physiotherapist. The primary outcome is bradykinesia of the lower limbs. The secondary outcomes are mobility, muscle power, dynamic balance, and quality of life. The effects of the training will be analyzed from the collected data by using the intention-to-treat analysis. Between-group differences will be measured by 2-way repeated measures ANOVA, considering the baseline, posttraining follow-up (primary time point), and 4-week follow-up (secondary time point). Results: Recruitment was conducted from October 2024 to October 2025 (n=46). Data collection is currently in the follow-up phase. The results are expected to be analyzed and submitted for publication by May 2026. Conclusions: The results of this trial will likely provide valuable new information on the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. If confirmed, these findings may support the feasibility and effectiveness of an accessible home-based intervention delivered through telerehabilitation, potentially reducing barriers to rehabilitation. Trial Registration: ClinicalTrials.gov NCT06646523; https://clinicaltrials.gov/study/NCT06646523 International Registered Report Identifier (IRRID): DERR1-10.2196/84689
- 11 November 2025
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 40 (2) , 238-245
Performance-based tests in individuals with Parkinson's disease: Outcome scores and reliability
Objective: To compare the outcome scores and reliability of performance-based tests (Timed “Up and Go,” 10-Meter Walk Test at comfortable and maximal speeds, and Five Times Sit-to-Stand Test) in individuals with Parkinson's disease, considering one repetition and the mean of two and three repetitions. Design: Reliability study. Setting: Research laboratory. Participants: 52 individuals with Parkinson's disease were included and assessed for inter-rater reliability (66.9 ± 6.2 years; 61.5% men) and 50 for test–retest reliability (67.1 ± 6.8 years; 62.5% men). Main measures: Assessments were conducted in two sessions, seven to 14 days apart, by two independent raters. Four performance-based tests were applied. ANOVA and intraclass correlation coefficient (ICC) were used (α=5%). Results: For all tests, the results were similar among the different outcome scores (0.269 ≤ F ≤ 0.046; 0.995 ≤ p ≤ 0.764), with high to very high test–retest reliability (0.73 ≤ ICC ≤ 0.96; p ≤ 0.001) and high to very high of inter-rater (0.84≤ ICC ≤ 0.96; p ≤ 0.001) reliabilities, except for Five Times Sit-to-Stand Test at one repetition, which inter-rater reliability was classified as moderate (ICC = 0.68; p ≤ 0.001). Conclusion: For all investigated tests, only one repetition, after familiarization, was necessary to provide consistent and reliable results for mobility assessment in individuals with Parkinson's disease.
- 11 November 2025
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 40 (2) , 238-245
Performance-based tests in individuals with Parkinson's disease: Outcome scores and reliability
Objective: To compare the outcome scores and reliability of performance-based tests (Timed “Up and Go,” 10-Meter Walk Test at comfortable and maximal speeds, and Five Times Sit-to-Stand Test) in individuals with Parkinson's disease, considering one repetition and the mean of two and three repetitions. Design: Reliability study. Setting: Research laboratory. Participants: 52 individuals with Parkinson's disease were included and assessed for inter-rater reliability (66.9 ± 6.2 years; 61.5% men) and 50 for test–retest reliability (67.1 ± 6.8 years; 62.5% men). Main measures: Assessments were conducted in two sessions, seven to 14 days apart, by two independent raters. Four performance-based tests were applied. ANOVA and intraclass correlation coefficient (ICC) were used (α=5%). Results: For all tests, the results were similar among the different outcome scores (0.269 ≤ F ≤ 0.046; 0.995 ≤ p ≤ 0.764), with high to very high test–retest reliability (0.73 ≤ ICC ≤ 0.96; p ≤ 0.001) and high to very high of inter-rater (0.84≤ ICC ≤ 0.96; p ≤ 0.001) reliabilities, except for Five Times Sit-to-Stand Test at one repetition, which inter-rater reliability was classified as moderate (ICC = 0.68; p ≤ 0.001). Conclusion: For all investigated tests, only one repetition, after familiarization, was necessary to provide consistent and reliable results for mobility assessment in individuals with Parkinson's disease.
- Open Access
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Effects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Exercises that involve increasing the speed of movements are beneficial for individuals with Parkinson disease (PD) and have the potential to reduce bradykinesia. High-speed bodyweight resistance training is accessible and versatile and can be performed anytime and anywhere, including at home. Furthermore, it is important to consider home exercises that enable treatment continuity and reduce barriers such as transportation difficulties and participation in physical exercise programs. However, we have not identified any studies that have conducted home-based high-speed bodyweight resistance training in individuals with PD. OBJECTIVE This protocol aims to investigate the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. METHODS A randomized controlled trial will be performed with 1:1 allocation, blinded assessments, and an intention-to-treat analysis. Altogether, 46 individuals with PD, aged ≥50 years, who have bradykinesia and a sedentary or insufficiently active lifestyle, will be included. Participants will be randomly assigned to either (1) an experimental group (high-speed bodyweight resistance training) or (2) a control group (bodyweight intervention; usual speed). Both groups will perform a home-based, remotely supervised intervention, consisting of 60-minute individual sessions, 3 times per week over 12 weeks, with a trained physiotherapist. The primary outcome is bradykinesia of the lower limbs. The secondary outcomes are mobility, muscle power, dynamic balance, and quality of life. The effects of the training will be analyzed from the collected data by using the intention-to-treat analysis. Between-group differences will be measured by 2-way repeated measures ANOVA, considering the baseline, posttraining follow-up (primary time point), and 4-week follow-up (secondary time point). RESULTS Recruitment was conducted from October 2024 to October 2025 (n=46). Data collection is currently in the follow-up phase. The results are expected to be analyzed and submitted for publication by May 2026. CONCLUSIONS The results of this trial will likely provide valuable new information on the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. If confirmed, these findings may support the feasibility and effectiveness of an accessible home-based intervention delivered through telerehabilitation, potentially reducing barriers to rehabilitation. CLINICALTRIAL ClinicalTrials.gov NCT06646523; https://clinicaltrials.gov/study/NCT06646523 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/84689
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND Exercises that involve increasing the speed of movements are beneficial for individuals with Parkinson disease (PD) and have the potential to reduce bradykinesia. High-speed bodyweight resistance training is accessible and versatile and can be performed anytime and anywhere, including at home. Furthermore, it is important to consider home exercises that enable treatment continuity and reduce barriers such as transportation difficulties and participation in physical exercise programs. However, we have not identified any studies that have conducted home-based high-speed bodyweight resistance training in individuals with PD. OBJECTIVE This protocol aims to investigate the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. METHODS A randomized controlled trial will be performed with 1:1 allocation, blinded assessments, and an intention-to-treat analysis. Altogether, 46 individuals with PD, aged ≥50 years, who have bradykinesia and a sedentary or insufficiently active lifestyle, will be included. Participants will be randomly assigned to either (1) an experimental group (high-speed bodyweight resistance training) or (2) a control group (bodyweight intervention; usual speed). Both groups will perform a home-based, remotely supervised intervention, consisting of 60-minute individual sessions, 3 times per week over 12 weeks, with a trained physiotherapist. The primary outcome is bradykinesia of the lower limbs. The secondary outcomes are mobility, muscle power, dynamic balance, and quality of life. The effects of the training will be analyzed from the collected data by using the intention-to-treat analysis. Between-group differences will be measured by 2-way repeated measures ANOVA, considering the baseline, posttraining follow-up (primary time point), and 4-week follow-up (secondary time point). RESULTS Recruitment was conducted from October 2024 to October 2025 (n=46). Data collection is currently in the follow-up phase. The results are expected to be analyzed and submitted for publication by May 2026. CONCLUSIONS The results of this trial will likely provide valuable new information on the effects of remotely supervised home-based high-speed bodyweight resistance training in reducing bradykinesia and improving mobility, muscle power, dynamic balance, and quality of life in individuals with PD. If confirmed, these findings may support the feasibility and effectiveness of an accessible home-based intervention delivered through telerehabilitation, potentially reducing barriers to rehabilitation. CLINICALTRIAL ClinicalTrials.gov NCT06646523; https://clinicaltrials.gov/study/NCT06646523 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/84689